Long-term follow-up after cure of Helicobacter pylori infection with 4 days of quadruple therapy

Alimentary Pharmacology and Therapeutics

Volumn 10, Issue 4, 1996, Pages 645-650

  Lai, J Y L ^b   De Boer, W A ^b   Driessen, W M M ^a   Geuskens, L M ^a  

^a ST JOSEPH HOSPITAL   (Netherlands)

^b ST ANNA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BISMUTH CITRATE; METRONIDAZOLE; OMEPRAZOLE; TETRACYCLINE;

ARTICLE; BACTERIAL INFECTION; BREATH ANALYSIS; CLINICAL ARTICLE; DRUG EFFICACY; ENDOSCOPY; HELICOBACTER PYLORI; HUMAN; PEPTIC ULCER; PRIORITY JOURNAL;

EID: 0030037831     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1996.43185000.x     Document Type: Article

References (33)

1. National Institute of Health. Consensus conference: 'Helicobacter pylori in peptic ulcer disease'. J Am Med Ass 1994; 272: 65-9.
2. Marshall BJ. Helicobacter pylori. Am J Gastroenterol 1994; 89: S116-28.
3. de Boer WA, Tytgat GNJ. The best therapy for Helicobacter pylori infection: should efficacy or side effect profile determine our choice? Scand J Gastroenterol 1195; 30: 401-7.
4. Thijs JC, Kuipers EJ, Van Zwet AA, Pena AS, de Graaf J. Treatment of Helicobacter pylori infections. Q J Med 1995; 88: 369-89.
5. Parsonnet J. The incidence of Helicobacter pylori infection. Aliment Pharmacol Ther 1995; 9 (Suppl. 2): 45-51.
6. Parsonnet J, Blazer MJ, Perez-Perez GI, Hargrett-Bean N, Tauxe RV. Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists. Gastroenterology 1992; 102: 41-6.
7. Kuipers EJ, Pena AS, v Kamp G, et al. Seroconversion for Helicobacter pylori. Lancet 1993; 342: 328-31.
8. de Boer WA, Driessen WMM, Tytgat GNJ. Only four days of quadruple therapy can effectively cure Helicobacter pylori infection. Aliment Pharmacol Ther 1995; 9: 633-8.
9. Xia HX, Gilvarry J, Beattie S, et al. Recrudescence of Helicobacter pylori infection in patients with healed duodenal ulcer after treatment with different regimens. Am J Gastroenterol 1995; 90: 1221-5.
10. Patchett S, Beattie S, Leen E, et al. Helicobacter pylori and duodenal ulcer recurrence. Am J Gastroenterol 1992; 87: 24-7.
11. Labenz J, Gyenes E, Rühl GH, Börsch G. Helicobacter pylori reinfection and clinical course of peptic ulcer disease in the first year post-amoxicillin/omeprazole treatment. Eur J Gastroenterol Hepatol 1992; 4: 893-6.
12. Sung JJY, Chung SCS, Ling TKW, et al. One year follow-up of duodenal ulcers after 1- weeks triple therapy for Helicobacter pylori. Am J Gastroenterol 1994; 89: 199-202.
13. 2 breath tests: concise communication. J Nucl Med 1981; 22: 955-8.
14. 14C-urea breath test in C. pylori gastritis. Gut 1989; 30: 789-803.
15. van de Wouw BAM, de Boer WA, Jansz AR, Roymans RTJM, Staals APG. Comparison of three commercially available enzyme-linked immunosorbent assays and biopsy-dependent diagnosis for detecting Helicobacter pylori infection. J Clin Microbiol 1996; 34: 94-7.
16. Marshall BJ. Helicobacter pylori. Quadrennial review. Am J Gastroenterol 1994; 89: S116-28.
17. Tytgat GNJ. Review article: treatments that impact favourably upon the eradication of H. pylori and ulcer recurrence. Aliment Pharmacol Ther 1994; 8: 359-68.
18. Burette A, Glupczynski Y, DePrez C. Evaluation of various multi-drug eradication regimens for Helicobacter pylori. Eur J Gastroenterol Hepatol 1992; 4: 817-23.
19. Borody TJ, Andrews P, Shortis NP, Hyland L. 7 day therapy for Helicobacter pylori. Gastroenterology 1995; 108: A68. (Abstract.)
20. de Boer WA, Driessen WMM, Jansz A, Tytgat GNJ. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet 1995; 345: 817-20.
21. de Boer WA, Driessen WMM, Potters HVPJ, et al. Randomized study comparing 1 with 2 weeks of quadruple therapy for eradicating Helicobacter pylori. Am J Gastroenterol 1994; 89: 1993-7.
22. Hosking SW, Ling TKW, Yung MY, et al. Randomised controlled trial of short term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer. Br Med J 1992; 305: 502-4.
23. Borody TJ, Andrews P, Fraccula G, Brandi SS, Bac H. Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori. Gut 1995; 37: 477-81.
24. Adamek RJ, Freitag M, Opferkuch W, Ruhl GH, Wegener M. Duration of therapy plays a decisive role in Helicobacter pylori eradication using omeprazole and amoxicillin. Am J Gastroenterol 1994; 89: 1362. (Abstract.)
25. Cutler FA, Prasad VM. Long-term follow-up of Helicobacter pylori serology after successful eradication. Am J Gastroenterol 1996; 91: 85-8.
26. Kosunen TU, Seppala K, Sarna S, Sipponen P. Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. Lancet 1992; 339: 893-5.
27. Hirsch AM, Brandstätter G, Dragosics B, et al. Kinetics of specific IgG antibodies for monitoring the effect of anti-Helicobacter pylori chemotherapy. J Infect Dis 1993; 168: 763-6.
28. Bell GD, Powell KU, Burridge SM, et al. Reinfection or recrudescence after apparently successful eradication of Helicobacter pylori infections: implications for treatment of patients with duodenal ulcer disease. Q J Med 1993; 86: 375-82.
29. Xia HX, Windl HJ, Marshall DG, et al. Recrudescence of Helicobacter pylori after apparently successful eradication: novel application of randomly amplified polymorphic DNA finger-printing. Gut 1995; 37: 30-4.
30. Tytgat GNJ. Helicobacter pylori infection and duodenal ulcer disease. J Intern Med 1992; 231: 199-203.
31. de Boer WA, Tytgat GNJ. Helicobacter pylori eradication and reinfection. Lancet 1995; 345: 1647-8. (Letter.)
32. 13C]-urea breath test. Am J Gastroenterol 1995; 90: 2069-70. (Letter.)
33. van Zwet AA, Thijs JC, Roosendaal R, et al. Practical diagnosis of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1996; 8: in press.